Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 49
Filter
Add more filters

Publication year range
1.
BMC Pediatr ; 19(1): 42, 2019 01 31.
Article in English | MEDLINE | ID: mdl-30704518

ABSTRACT

BACKGROUND: Brazil introduced the monovalent rotavirus vaccine (Rotarix®) in 2006. This study aimed to assess the epidemiology and genotype distribution of species-A rotavirus (RVA) in Brazil, comparing the pre- and post-vaccination periods. METHODS: Laboratory-based RVA surveillance included 866 municipalities in 22 Brazilian states, over a 21-year period. A total of 16,185 children with diarrheal diseases (DD) aged up to 12 years between 1996 and 2005 (pre-vaccination period, n = 7030) and from 2006 to 2017 (post-vaccination period, n = 9155) were enrolled. RVA was detected using ELISA immune assay and/or polyacrylamide gel electrophoresis and genotyped using nested PCR and/or nucleotide sequencing. RVA-positivity and genotypes detection rates were compared in distinct periods and age groups and Rotarix vaccination status. RESULTS: RVA-positivity in pre- and post-vaccination periods was, respectively: 4-11 months bracket, 33.3% (668/2006) and 16.3% (415/2547) (p <  0.001); 12-24 months, 28.2% (607/2154) and 22.2% (680/3068) (p <  0.001); 25-48 months, 17.4% (215/1235) and 29.4% (505/1720) (p <  0.001). Genotypes distribution in the pre- and post-vaccination periods was, respectively: G1P [8]/G1P[Not Typed], 417/855 (48.8%) and 118/1835 (6.4%) (p <  0.001); G2P [4]/G2P[NT], 47/855 (5.5%) and 838/1835 (45.7%) (p <  0.001); G3P [8]/G3P[NT], 55/855 (6.4%) and 253/1835 (13.8%) (p <  0.001); G9P [8]/G9P[NT], 238/855 (27.8%) and 152/1835 (8.3%) (p <  0.001); G12P [8]/G129P[NT], 0/871 (0%) and 249/1835(13.6%) (p <  0.001). Concerning infants aged 4-11 months, RVA frequency in fully vaccinated and non-vaccinated individuals was 11.9% (125/1052) and 24.5% (58/237) (p <  0.001), respectively. In children aged 12-24 months, RVA detection rate was 18.1% (253/1395) and 29.6% (77/260) (p <  0.001), for the vaccinated and non-vaccinated individuals, respectively (p <  0.001). CONCLUSIONS: RVA infection was significantly less frequent in children aged ≤2 years with DD after implementing vaccination, mainly among vaccinated children. It was also observed a decrease of P [8] circulation and emergence of G2P[4] in 2005, and afterwards in the post-vaccine era, with spreading of G12P[8] in 2014-2015 and of G3P[8] in 2017. Continuous RVA surveillance must be carried out in this scenario.


Subject(s)
Rotavirus Infections/epidemiology , Rotavirus Infections/prevention & control , Rotavirus Vaccines , Brazil/epidemiology , Child , Child, Preschool , Genotype , Humans , Infant , Retrospective Studies , Rotavirus/classification , Rotavirus/genetics , Rotavirus Infections/virology , Time Factors , Vaccination Coverage , Vaccines, Attenuated
2.
J Infect Dis ; 216(2): 220-227, 2017 07 15.
Article in English | MEDLINE | ID: mdl-28838152

ABSTRACT

Background: The etiology of acute watery diarrhea remains poorly characterized, particularly after rotavirus vaccine introduction. Methods: We performed quantitative polymerase chain reaction for multiple enteropathogens on 878 acute watery diarrheal stools sampled from 14643 episodes captured by surveillance of children <5 years of age during 2013-2014 from 16 countries. We used previously developed models of the association between pathogen quantity and diarrhea to calculate pathogen-specific weighted attributable fractions (AFs). Results: Rotavirus remained the leading etiology (overall weighted AF, 40.3% [95% confidence interval {CI}, 37.6%-44.3%]), though the AF was substantially lower in the Americas (AF, 12.2 [95% CI, 8.9-15.6]), based on samples from a country with universal rotavirus vaccination. Norovirus GII (AF, 6.2 [95% CI, 2.8-9.2]), Cryptosporidium (AF, 5.8 [95% CI, 4.0-7.6]), Shigella (AF, 4.7 [95% CI, 2.8-6.9]), heat-stable enterotoxin-producing Escherichia coli (ST-ETEC) (AF, 4.2 [95% CI, 2.0-6.1]), and adenovirus 40/41 (AF, 4.2 [95% CI, 2.9-5.5]) were also important. In the Africa Region, the rotavirus AF declined from 54.8% (95% CI, 48.3%-61.5%) in rotavirus vaccine age-ineligible children to 20.0% (95% CI, 12.4%-30.4%) in age-eligible children. Conclusions: Rotavirus remained the leading etiology of acute watery diarrhea despite a clear impact of rotavirus vaccine introduction. Norovirus GII, Cryptosporidium, Shigella, ST-ETEC, and adenovirus 40/41 were also important. Prospective surveillance can help identify priorities for further reducing the burden of diarrhea.


Subject(s)
Diarrhea/epidemiology , Diarrhea/microbiology , Diarrhea/virology , Rotavirus Infections/prevention & control , Rotavirus Vaccines/therapeutic use , Africa/epidemiology , Asia/epidemiology , Brazil/epidemiology , Child, Preschool , Feces/microbiology , Feces/virology , Female , Global Health , Humans , Infant , Logistic Models , Male , Polymerase Chain Reaction , Retrospective Studies , World Health Organization
3.
J Med Virol ; 87(9): 1480-90, 2015 Sep.
Article in English | MEDLINE | ID: mdl-25982627

ABSTRACT

Group A rotaviruses (RVA) and noroviruses (NoV) are the leading cause of acute gastroenteritis (AGE) worldwide. Childhood diarrhea deaths and hospital admissions have declined since the introduction of the monovalent (G1P[8]) vaccine (Rotarix(®) [RV1]) in the National Immunization Program in Brazil in 2006. This study aims to investigate the epidemiological profile of NoV and RVA infections from children with AGE in the Northeastern region of Brazil in the post vaccine season. Two-hundred fecal samples collected from children up to 10 years old in Fortaleza, Ceará between 2008-2009 were screened for the presence of RVA and NoV. Positive samples were genotyped and sequenced. The RVA screening revealed 12% prevalence and all RVA strains belonged to G2P[4] genotype. Phylogenetic analysis based on the 11 RVA genome segments sequenced from eight samples revealed a DS-1-like genotype constellation: I2-R2-C2-M2-A2-N2-T2-E2-H2. For NoV screening, the prevalence observed was 17% and the following genotypes were detected: GII.4 (59%), GII.12 (17%), GII.6 (9%), GII.3 (6%), and GII.? (9%). At least four different NoVs genotypes and two RVA G2P[4] variants were identified circulating in the Northeastern region of Brazil. RVA phylogenetic analysis suggests that the RVA G2P[4] strains might have originated from intragenogroup reassortment events. Whether the genetic modifications observed in these contemporary G2P[4] RVA strains may impact the long-term effectiveness of the current vaccination programs remains to be explored. These data reinforce the importance of surveillance for monitoring the emergence of new strains of RVA and NoV and their impact on cases of acute gastroenteritis.


Subject(s)
Caliciviridae Infections/virology , Feces/virology , Gastroenteritis/virology , Norovirus/genetics , Rotavirus Infections/virology , Rotavirus Vaccines , Rotavirus/genetics , Amino Acid Sequence , Brazil/epidemiology , Capsid Proteins/genetics , Child , Child, Preschool , Female , Gastroenteritis/etiology , Genetic Variation , Genome, Viral , Genotype , Humans , Infant , Male , Phylogeny , RNA, Viral/genetics , Rotavirus Infections/epidemiology , Seasons , Sequence Analysis, DNA , Vaccination , Vaccines, Attenuated
4.
J Med Virol ; 86(12): 2065-9, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25042068

ABSTRACT

The monitoring of environmental microbial contamination in healthcare facilities may be a valuable tool to determine pathogens transmission in those settings; however, such procedure is limited to bacterial indicators. Viruses are found commonly in those environments and are rarely used for these procedures. The aim of this study was to assess distribution and viability of a human DNA virus on fomites in an Adult Intensive Care Unit of a private hospital in Rio de Janeiro, Brazil. Human adenoviruses (HAdV) were investigated in 141 fomites by scraping the surface area and screening by quantitative PCR (qPCR) using TaqMan® System (Carlsbad, CA). Ten positive samples were selected for virus isolation in A549 and/or HEp2c cell lines. A total of 63 samples (44.7%) were positive and presented viral load ranging from 2.48 × 10(1) to 2.1 × 10(3) genomic copies per millilitre (gc/ml). The viability was demonstrated by integrated cell culture/nested-PCR in 5 out of 10 samples. Nucleotide sequencing confirmed all samples as HAdV and characterized one of them as specie B, serotype 3 (HAdV-3). The results indicate the risk of nosocomial transmission via contaminated fomites and point out the use of HAdV as biomarkers of environmental contamination.


Subject(s)
Adenoviruses, Human/isolation & purification , Adenoviruses, Human/physiology , Fomites/virology , Hospitals , Microbial Viability , Adult , Brazil , Cell Line , Epithelial Cells/virology , Genotype , Hepatocytes/virology , Humans , Intensive Care Units , Real-Time Polymerase Chain Reaction , Serogroup , Viral Load , Virus Cultivation
5.
Arch Virol ; 159(7): 1827-33, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24493066

ABSTRACT

Bovine herpesvirus type 5 (BoHV-5) is an etiologic agent of meningoencephalitis in cattle. The aim of this study was to evaluate the antiviral potential of a series of synthetic Mannich bases derived from lawsone and to investigate at which stage of the BoHV-5 replicative cycle the compounds might be acting. The most potent and selective inhibitor exhibited CC50 and EC50 values of 1867 µM ± 8.3 and 3.8 µM ± 1.2, respectively (ACV: 989 µM ± 2 and 166 µM ± 2, respectively).


Subject(s)
Antiviral Agents/pharmacology , Herpesvirus 5, Bovine/drug effects , Naphthoquinones/pharmacology , Virus Replication/drug effects , Acyclovir/pharmacology , Animals , Antiviral Agents/chemistry , Cell Line , Dogs , Dose-Response Relationship, Drug , Herpesvirus 5, Bovine/physiology , Molecular Structure , Naphthoquinones/chemistry , Viral Plaque Assay
6.
PLOS Glob Public Health ; 3(11): e0001358, 2023.
Article in English | MEDLINE | ID: mdl-38015834

ABSTRACT

Rotavirus is the most common pathogen causing pediatric diarrhea and an important cause of morbidity and mortality in low- and middle-income countries. Previous evidence suggests that the introduction of rotavirus vaccines in national immunization schedules resulted in dramatic declines in disease burden but may also be changing the rotavirus genetic landscape and driving the emergence of new genotypes. We report genotype data of more than 16,000 rotavirus isolates from 40 countries participating in the Global Rotavirus Surveillance Network. Data from a convenience sample of children under five years of age hospitalized with acute watery diarrhea who tested positive for rotavirus were included. Country results were weighted by their estimated rotavirus disease burden to estimate regional genotype distributions. Globally, the most frequent genotypes identified after weighting were G1P[8] (31%), G1P[6] (8%) and G3P[8] (8%). Genotypes varied across WHO Regions and between countries that had and had not introduced rotavirus vaccine. G1P[8] was less frequent among African (36 vs 20%) and European (33 vs 8%) countries that had introduced rotavirus vaccines as compared to countries that had not introduced. Our results describe differences in the distribution of the most common rotavirus genotypes in children with diarrhea in low- and middle-income countries. G1P[8] was less frequent in countries that had introduced the rotavirus vaccine while different strains are emerging or re-emerging in different regions.

7.
J Water Health ; 8(3): 438-45, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20375473

ABSTRACT

Polyomavirus JC (JCPyV) is largely excreted by the human population through the urinary route and has been recognized as a potential viral marker for human waste contamination. This study aims to investigate the dissemination of JCPyV in waste water from a sewage treatment plant (STP) located in Rio de Janeiro, Brazil, and to describe the prevalence of JCPyV subtypes currently present in this population. Raw and treated sewage samples were collected bimonthly during one year, and examined for the presence of JCPyV using nested polymerase chain reaction (nPCR) and quantitative real time PCR (qPCR). JCPyV was detected by nPCR in 96% and 43% of raw and treated sewage samples, respectively. The concentration of JCPyV present in the samples ranged from 1.2x10(3) to 3.2x10(5) and 2.6x10(2) to 6.2x10(3) genome copies per 2 ml of concentrated raw and treated sewage sample, respectively. The strains were characterized and the obtained nucleotide sequences indicated that the detected JCPyV strains clustered with subtypes of East African, West African and European origin. To our knowledge, this is the first study describing the incidence and diversity of JCPyV strains in raw and treated sewage in Brazil.


Subject(s)
DNA, Viral/analysis , JC Virus/isolation & purification , Sewage/virology , Water Microbiology , Base Sequence , Brazil , Environmental Monitoring , Humans , JC Virus/genetics , Phylogeny , Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction
8.
Mem Inst Oswaldo Cruz ; 105(8): 1068-72, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21225209

ABSTRACT

Rotaviruses are important enteric pathogens for humans and animals. Group A rotaviruses (RV-A) are the most common agents of severe gastroenteritis in infants and young children and vaccination is the most effective method to reduce RV-A-associated diseases. G1P[8], the most prevalent RV-A genotype worldwide, is included in the RV-A vaccine Rotarix®. The discrimination between wild-type G1P[8] and vaccine G1P[8] strains is an important topic in the study of RV-A epidemiology to manage outbreaks and to define control measures for vaccinated children. In this study, we developed a novel method to segregate the wild-type and vaccine strains using restriction endonucleases. The dsRNA from the Rotarix® vaccine was sequenced and the NSP3 gene was selected as the target gene. The vaccine strain has a restriction pattern that is different than that of wild-type RV-A G1P[8] isolates after digestion with the restriction endonuclease BspHI. This pattern could be used as a marker for the differentiation of wild-type G1P[8] strains from the vaccine strain.


Subject(s)
Feces/virology , Rotavirus Vaccines/genetics , Rotavirus/genetics , DNA Restriction Enzymes/genetics , Genotype , Humans , Polymorphism, Restriction Fragment Length , Rotavirus/isolation & purification , Rotavirus Infections/virology , Vaccines, Attenuated/genetics
9.
Antivir Ther ; 25(1): 13-20, 2020.
Article in English | MEDLINE | ID: mdl-31538962

ABSTRACT

BACKGROUND: Bovine herpesvirus type 5 is an important agent of meningoencephalitis in cattle and has been identified in outbreaks of bovine neurological disease in several Brazilian states. In recent years, oxoquinoline derivatives have become an important focus in antiviral drug research. METHODS: The cytotoxicity and anti BoHV-5RJ42/01 activity of a set of synthetic 4-oxoquinoline derivatives 4a-k were assayed on Madin-Darby Bovine Kidney cell and antiviral activity by plaque reduction assay. RESULTS: The most promising substance (4h) exhibited CC50 and EC50 values of 1,239 µM ±5.5 and 6.0 µM ±1.5, respectively, with an SI =206. Two other compounds 4j (CC50 = 35 µM ±2 and EC50 = 24 µM ±7.0) and 4k (CC50= 55 µM ±2 and EC50 = 24 µM ±5.1) presented similar inhibitory profile and selectivity indexes of 1.4 and 2.9, respectively. The results of the time-of-addition studies revealed expressive reduction of virus production (≥80%) in different stages of virus replication cycle except for compound 4h that slightly inhibited virus yield in the first 2 h post infection, but it showed expressive virus inhibition after this time. CONCLUSIONS: All three compounds slightly interact with the virus on the virucidal assay and they are not able to block virus attachment and penetration. Antiviral effect of oxoquinoline 4h was more prominent than acyclovir which leads us to suggest compound 4h as a promising molecule for further anti-BoHV-5 drug design.


Subject(s)
4-Quinolones/pharmacology , Antiviral Agents/pharmacology , Herpesvirus 5, Bovine/drug effects , Animals , Dogs , Madin Darby Canine Kidney Cells/drug effects , Viral Plaque Assay , Virus Inactivation/drug effects , Virus Replication/drug effects
10.
J Virol Methods ; 155(1): 39-43, 2009 Jan.
Article in English | MEDLINE | ID: mdl-18951920

ABSTRACT

Noroviruses (NoVs) are recognized as the most common agents of outbreaks of food-borne viral gastroenteritis and the efficiency of different methods for detection of NoVs from food matrices have been tested in several laboratories worldwide. The aim of this study was to develop a rapid and sensitive method for recovery of NoVs by using a filtration concentration method followed by PCR amplification for detection of NoVs from cheese and fresh lettuce. Experimentally, a fecal suspension containing different number of NoVs copies was spiked in the food surface and extracted by a direct elution using a Stomacher apparatus. An Ozone-Safe solvent Vertrel XF treatment was included for cheese samples for removing particulate matter. The watery phase was collected and the viral concentration was performed by the adsorption-elution method using negatively charged membranes with inorganic solvents in a Stericup and afterwards ultrafiltered using a Centriprep Concentrator 50 to obtain a final volume of 2ml. RNA isolation was carried out with the QIAamp Viral RNA Mini Kit available commercially and reverse transcription was carried out with a Pd(N6) random primer. Real time quantitative PCR (TaqMan) and qualitative PCR were used for molecular detection of NoVs. The recovery rate of NoVs ranged from 5.2 to 72.3% in lettuce and from 6 to 56.3% in cheese. The results indicate that this method is suitable for detection of NoVs contamination in food and will help establish the cause and source of NoVs outbreaks of food-borne illness.


Subject(s)
Cheese/virology , Food Contamination/analysis , Lactuca/virology , Norovirus/isolation & purification , Feces/virology , Food Microbiology , Gastroenteritis/virology , Humans , Norovirus/genetics , Polymerase Chain Reaction/methods , RNA, Viral/analysis , RNA, Viral/isolation & purification , Reverse Transcriptase Polymerase Chain Reaction/methods , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL